Company news
Shanghai Medicilon, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(688202)"Shanghai Medicilon Inc."Report for Q3 2026
October 29, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Opening a Special Account for Raised Funds and Authorizing the Signing of a Supervision Agreement for Such Account
October 29, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction
October 29, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Expiration of the Lock-up Period and Satisfaction of Unlocking Conditions under the 2025 Employee Stock Ownership Plan
October 28, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Release of Freezing of Certain Shares Held by the Shareholder
October 23, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Correction of the Notice of the 1st Extraordinary General Meeting in 2026
October 15, 2026
(688202)"Shanghai Medicilon Inc."Notice on Convening the 1st Extraordinary General Meeting in 2026
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Satisfaction of Vesting Conditions for the First Vesting Period of the Initial Grant and Reserved Grant under the 2025 Restricted Share Incentive Plan
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Resolutions of the 15th Meeting of the 4th Board of Directors
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Opening a Special Account for Raised Funds and Authorizing the Signing of a Supervision Agreement for Such Account
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on New Raised Funds Investment Project
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Cancellation of Certain Granted but Unvested 2025 Restricted Shares
October 14, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Shareholding Reduction Plan of Senior Executive
October 13, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Expiration of Shareholding Reduction Plan of Shareholder and Results of Shareholding Reduction
October 12, 2026
(688202)"Shanghai Medicilon Inc."Announcement on Progress of Litigation Involving the Subsidiary
October 9, 2026
Indicative Announcement on Change in Equity Interests of Shareholder Reaching 1% Threshold
September 21, 2026
Announcement on Progress of Litigation Involving the Subsidiary
September 18, 2026
Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 24, 2026
Announcement on Shareholding Reduction Plan of Shareholder
August 14, 2026
Announcement on Use of Certain Temporarily Idle Raised Funds for Cash Management
August 7, 2026
Indicative Announcement on Shareholders' Equity Change Reaching the 1% Threshold
July 13, 2026
Announcement on Subsidiary Filing a Counterclaim
June 26, 2026
Announcement on Release of Pledge of Shareholder's Shares
June 24, 2026
Announcement on Shareholding Reduction Plan for Shareholders
June 12, 2026
Announcement on Lifting Freeze of Partial Equity of Shareholder
June 1, 2026
Announcement on Election of Employee Representative Directors for the 4th Board of Directors
May 22, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Announcement on Participating in the "Dialogue on Growth" 2025 Annual and Q1 2026 Performance Briefing
May 7, 2026
Report for Q1 2026
April 29, 2026
Announcement on Formulating and Revising Some Governance Systems
April 22, 2026
Announcement on Using Idle Self-owned Funds for Cash Management
April 3, 2026
Announcement on Release of Pledge of Partial Equity of Shareholder
March 30, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
SHANGHAI MEDICILON INC.: Earnings Preannouncement for 2025
January 30, 2026
Announcement on Early Termination of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction
January 25, 2026
Announcement on Adjustment of Investment Types for Cash Management Using Idle Own Funds
November 21, 2025
Announcement on Shareholding Reduction Plan for Shareholder
November 19, 2025
Announcement on Expiration of Plan by Shareholder and Results of Shareholding Reduction
November 11, 2025
Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
October 30, 2025
Announcement on the Completion of Non-Trade Stock Transfer under the 2025 Employee Stock Ownership Plan
October 28, 2025
Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan
September 24, 2025
Self-Inspection Report on the Trading of the Company's Stocks by Information Insiders of 2025 Restricted Stock Incentive Plan
September 15, 2025
Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2025 Restricted Stock Incentive Plan
September 8, 2025
Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025
September 5, 2025
Announcement on Litigation Involving Subsidiary
September 4, 2025
Special Report on Semi-annual Deposit, Management and Actual Use of Raised Funds in 2025
August 28, 2025
Announcement on Resolutions of the 5th Meeting of the 4th Board of Supervisors
August 8, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
July 14, 2025
Announcement on Abnormal Fluctuations in Stock Trading
July 9, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
July 1, 2025